An evaluation of intermittent therapies used to treat onychomycosis and other dermatomycoses with the oral antifungal agents.
Gupta
A K
AK
Department of Medicine, Sunnybrook and Women's College Health Sciences Center, University of Toronto, Canada. agupta@execulink.com
Del Rosso
J Q
JQ
D000284:Administration, Oral; D000935:Antifungal Agents / Q000008:administration & dosage*; D002986:Clinical Trials as Topic; D003881:Dermatomycoses / Q000188:drug therapy*; D004334:Drug Administration Schedule; D015725:Fluconazole / Q000008:administration & dosage; D006118:Griseofulvin / Q000008:administration & dosage; D006801:Humans; D017964:Itraconazole / Q000008:administration & dosage; D007654:Ketoconazole / Q000008:administration & dosage; D009281:Naphthalenes / Q000008:administration & dosage; D014009:Onychomycosis / Q000188:drug therapy*; D000077291:Terbinafine
D000935:Antifungal Agents; D009281:Naphthalenes; D017964:Itraconazole; D006118:Griseofulvin; D015725:Fluconazole; D000077291:Terbinafine; D007654:Ketoconazole